Pauline Latzer
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccination.
Journal: Journal for immunotherapy of cancer
Published: May 12, 2025
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.
Journal: Nature communications
Published: February 29, 2024
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer.
Journal: Frontiers in immunology
Published: August 02, 2023
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
Journal: Journal of neurochemistry
Published: January 06, 2021
Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy.
Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy.
Journal: Journal of neurochemistry
Published: October 01, 2019
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma.
Journal: Journal of neuro-oncology
Published: September 24, 2019
Blocking VEGF by Bevacizumab Compromises Electrophysiological and Morphological Properties of Hippocampal Neurons.
Journal: Frontiers in cellular neuroscience
Published: November 21, 2018
Influence of vascular endothelial growth factor and radiation on gap junctional intercellular communication in glioblastoma multiforme cell lines.
Journal: Neural regeneration research
Published: December 15, 2017
Morphological Changes of Cortical and Hippocampal Neurons after Treatment with VEGF and Bevacizumab.
Morphological Changes of Cortical and Hippocampal Neurons after Treatment with VEGF and Bevacizumab.
Journal: CNS neuroscience & therapeutics
Published: September 11, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026